F.D.A. Approves A.L.S. Treatment Despite Questions About Effectiveness

Health
By BY PAM BELLUCK from NYT Health https://ift.tt/2POrKbL
via IFTTT your-feed-science, Clinical Trials, Drugs (Pharmaceuticals), Amyotrophic Lateral Sclerosis, your-feed-healthcare The drug is safe, and one trial found it may extend survival and slow paralysis in functions like muscle control and speaking. A larger trial will be completed in 2024.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda